Effect of dulaglutide in promoting abstinence during smoking cessation: 12-month follow-up of a single-centre, randomised, double-blind, placebo-controlled, parallel group trialResearch in context

Effect of dulaglutide in promoting abstinence during smoking cessation: 12-month follow-up of a single-centre, randomised, double-blind, placebo-controlled, parallel group trialResearch in context

Summary: Background: Smoking cessation is challenging, despite making use of established smoking cessation therapies. Preclinical studies and one clinical pilot study suggest the antidiabetic drug glucagon-like peptide-1 (GLP-1) analogue to modulate addictive behaviours and nicotine craving. Previo...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Hualin Lüthi, Sophia Lengsfeld, Thilo Burkard, Andrea Meienberg, Nica Jeanloz, Tanja Vukajlovic, Katja Bologna, Michelle Steinmetz, Cemile Bathelt, Clara O. Sailer, Mirjam Laager, Deborah R. Vogt, Lars G. Hemkens, Benjamin Speich, Sandrine A. Urwyler, Jill Kühne, Fabienne Baur, Linda N. Lutz, Tobias E. Erlanger, Mirjam Christ-Crain, Bettina Winzeler
التنسيق: مقال
اللغة:English
منشور في: Elsevier 2024-02-01
سلاسل:EClinicalMedicine
الموضوعات:
Glucagon-like peptide-1 (GLP-1) analogues
Quitting smoking
Long-term abstinence
Post-cessation weight gain
الوصول للمادة أونلاين:http://www.sciencedirect.com/science/article/pii/S2589537024000087

الانترنت

http://www.sciencedirect.com/science/article/pii/S2589537024000087

مواد مشابهة